Comments
Novo Nordisk could drop blood drug candidate-exec
11.08.2012. | COPENHAGEN (Reuters) - Denmark's Novo Nordisk could be a few months away from dropping a drug expected to replace crucial blood treatment Novoseven and seen as a potential blockbuster, the company said on Friday....
